Rationale, design, and preliminary results of the Quebec Warfarin Cohort Study Article Swipe
Sylvie Perreault
,
Payman Shahabi
,
Robert Côté
,
Stéphanie Dumas
,
Étienne Rouleau‐Mailloux
,
Yassamin Feroz Zada
,
Sylvie Provost
,
Ian Mongrain
,
Marc Dorais
,
Thao Huynh
,
Simon Kouz
,
Ariel Díaz
,
Mark Blostein
,
Simon de Denus
,
Jacques Turgeon
,
Jeffrey S. Ginsberg
,
Jacques LeLorier
,
Lyne Lalonde
,
Lambert Busque
,
Jeannine Kassis
,
Mario Talajic
,
Jean‐Claude Tardif
,
Marie‐Pierre Dubé
·
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.1002/clc.22948
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.1002/clc.22948
Over‐ and undercoagulation with warfarin are associated with hemorrhagic and thromboembolic events, respectively. Genetic and clinical factors affect warfarin response, and the causes of this variability remain unclear. We present descriptive statistics and test for predictors of poor anticoagulation control. The Quebec Warfarin Cohort (QWC) comprises 1059 new warfarin users, with prospective follow‐up using telephone questionnaires every 3 months for 1 year, and using healthcare administrative databases (RAMQ and Med‐Echo) for 5 years prior to cohort entry and up to 10 years following active patient participation. Genetic material was collected, and genotyping of CYP2C9 and VKORC1 genes was conducted. Measured outcomes included the percentage of time patients spent within therapeutic range, anticoagulation control, warfarin dose, bleeding, and thromboembolic events. We report baseline characteristics and outcomes after 1 year of follow‐up. Poor anticoagulation control was defined as time in therapeutic range <60% in the 3‐ to 12‐month interval. Participants had a mean age of 71 years, and 62% were men. The most common indication for warfarin was atrial fibrillation (87%). Mean time in therapeutic range was 56% (±25%) in the 3 months following warfarin initiation, and 70% (±21%) in the 3‐ to 12‐month interval. During follow‐up, the rate of stroke or systemic embolism was 1.8 events per 100 person‐years; for major bleeding events, 3.3 events per 100 person‐years. Independent predictors of poor anticoagulation control were chronic kidney disease, heart failure, dyslipidemia, and age. The QWC represents a good research cohort to investigate clinical and genetic factors in a warfarin‐anticoagulated population.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1002/clc.22948
- https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/clc.22948
- OA Status
- bronze
- Cited By
- 22
- References
- 37
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2794150831
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2794150831Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1002/clc.22948Digital Object Identifier
- Title
-
Rationale, design, and preliminary results of the Quebec Warfarin Cohort StudyWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2018Year of publication
- Publication date
-
2018-03-15Full publication date if available
- Authors
-
Sylvie Perreault, Payman Shahabi, Robert Côté, Stéphanie Dumas, Étienne Rouleau‐Mailloux, Yassamin Feroz Zada, Sylvie Provost, Ian Mongrain, Marc Dorais, Thao Huynh, Simon Kouz, Ariel Díaz, Mark Blostein, Simon de Denus, Jacques Turgeon, Jeffrey S. Ginsberg, Jacques LeLorier, Lyne Lalonde, Lambert Busque, Jeannine Kassis, Mario Talajic, Jean‐Claude Tardif, Marie‐Pierre DubéList of authors in order
- Landing page
-
https://doi.org/10.1002/clc.22948Publisher landing page
- PDF URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/clc.22948Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/clc.22948Direct OA link when available
- Concepts
-
Medicine, Warfarin, Cohort, Internal medicine, Atrial fibrillation, Cohort study, Stroke (engine), VKORC1, Prospective cohort study, Pediatrics, Intensive care medicine, CYP2C9, Mechanical engineering, Cytochrome P450, Metabolism, EngineeringTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
22Total citation count in OpenAlex
- Citations by year (recent)
-
2024: 3, 2023: 4, 2022: 6, 2021: 5, 2020: 1Per-year citation counts (last 5 years)
- References (count)
-
37Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2794150831 |
|---|---|
| doi | https://doi.org/10.1002/clc.22948 |
| ids.doi | https://doi.org/10.1002/clc.22948 |
| ids.mag | 2794150831 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/29542828 |
| ids.openalex | https://openalex.org/W2794150831 |
| fwci | 1.78601255 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D000368 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Aged |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D000369 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Aged, 80 and over |
| mesh[2].qualifier_ui | Q000008 |
| mesh[2].descriptor_ui | D000925 |
| mesh[2].is_major_topic | False |
| mesh[2].qualifier_name | administration & dosage |
| mesh[2].descriptor_name | Anticoagulants |
| mesh[3].qualifier_ui | Q000009 |
| mesh[3].descriptor_ui | D000925 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | adverse effects |
| mesh[3].descriptor_name | Anticoagulants |
| mesh[4].qualifier_ui | Q000187 |
| mesh[4].descriptor_ui | D001777 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | drug effects |
| mesh[4].descriptor_name | Blood Coagulation |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D002985 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Clinical Protocols |
| mesh[6].qualifier_ui | Q000235 |
| mesh[6].descriptor_ui | D065729 |
| mesh[6].is_major_topic | False |
| mesh[6].qualifier_name | genetics |
| mesh[6].descriptor_name | Cytochrome P-450 CYP2C9 |
| mesh[7].qualifier_ui | Q000378 |
| mesh[7].descriptor_ui | D065729 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | metabolism |
| mesh[7].descriptor_name | Cytochrome P-450 CYP2C9 |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D016208 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Databases, Factual |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D005260 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Female |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D019538 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Health Care Surveys |
| mesh[11].qualifier_ui | Q000139 |
| mesh[11].descriptor_ui | D006470 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | chemically induced |
| mesh[11].descriptor_name | Hemorrhage |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D006801 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Humans |
| mesh[13].qualifier_ui | |
| mesh[13].descriptor_ui | D008019 |
| mesh[13].is_major_topic | False |
| mesh[13].qualifier_name | |
| mesh[13].descriptor_name | Life Style |
| mesh[14].qualifier_ui | |
| mesh[14].descriptor_ui | D008297 |
| mesh[14].is_major_topic | False |
| mesh[14].qualifier_name | |
| mesh[14].descriptor_name | Male |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D008875 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Middle Aged |
| mesh[16].qualifier_ui | |
| mesh[16].descriptor_ui | D010597 |
| mesh[16].is_major_topic | False |
| mesh[16].qualifier_name | |
| mesh[16].descriptor_name | Pharmacogenetics |
| mesh[17].qualifier_ui | |
| mesh[17].descriptor_ui | D000071184 |
| mesh[17].is_major_topic | False |
| mesh[17].qualifier_name | |
| mesh[17].descriptor_name | Pharmacogenomic Variants |
| mesh[18].qualifier_ui | |
| mesh[18].descriptor_ui | D000074286 |
| mesh[18].is_major_topic | False |
| mesh[18].qualifier_name | |
| mesh[18].descriptor_name | Preliminary Data |
| mesh[19].qualifier_ui | |
| mesh[19].descriptor_ui | D011446 |
| mesh[19].is_major_topic | False |
| mesh[19].qualifier_name | |
| mesh[19].descriptor_name | Prospective Studies |
| mesh[20].qualifier_ui | |
| mesh[20].descriptor_ui | D011792 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | |
| mesh[20].descriptor_name | Quebec |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D012107 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Research Design |
| mesh[22].qualifier_ui | |
| mesh[22].descriptor_ui | D012307 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | |
| mesh[22].descriptor_name | Risk Factors |
| mesh[23].qualifier_ui | Q000097 |
| mesh[23].descriptor_ui | D013923 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | blood |
| mesh[23].descriptor_name | Thromboembolism |
| mesh[24].qualifier_ui | Q000209 |
| mesh[24].descriptor_ui | D013923 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | etiology |
| mesh[24].descriptor_name | Thromboembolism |
| mesh[25].qualifier_ui | Q000517 |
| mesh[25].descriptor_ui | D013923 |
| mesh[25].is_major_topic | False |
| mesh[25].qualifier_name | prevention & control |
| mesh[25].descriptor_name | Thromboembolism |
| mesh[26].qualifier_ui | |
| mesh[26].descriptor_ui | D013997 |
| mesh[26].is_major_topic | False |
| mesh[26].qualifier_name | |
| mesh[26].descriptor_name | Time Factors |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D016896 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Treatment Outcome |
| mesh[28].qualifier_ui | Q000235 |
| mesh[28].descriptor_ui | D064417 |
| mesh[28].is_major_topic | False |
| mesh[28].qualifier_name | genetics |
| mesh[28].descriptor_name | Vitamin K Epoxide Reductases |
| mesh[29].qualifier_ui | Q000378 |
| mesh[29].descriptor_ui | D064417 |
| mesh[29].is_major_topic | False |
| mesh[29].qualifier_name | metabolism |
| mesh[29].descriptor_name | Vitamin K Epoxide Reductases |
| mesh[30].qualifier_ui | Q000008 |
| mesh[30].descriptor_ui | D014859 |
| mesh[30].is_major_topic | False |
| mesh[30].qualifier_name | administration & dosage |
| mesh[30].descriptor_name | Warfarin |
| mesh[31].qualifier_ui | Q000009 |
| mesh[31].descriptor_ui | D014859 |
| mesh[31].is_major_topic | False |
| mesh[31].qualifier_name | adverse effects |
| mesh[31].descriptor_name | Warfarin |
| mesh[32].qualifier_ui | |
| mesh[32].descriptor_ui | D000368 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | |
| mesh[32].descriptor_name | Aged |
| mesh[33].qualifier_ui | |
| mesh[33].descriptor_ui | D000369 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | |
| mesh[33].descriptor_name | Aged, 80 and over |
| mesh[34].qualifier_ui | Q000008 |
| mesh[34].descriptor_ui | D000925 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | administration & dosage |
| mesh[34].descriptor_name | Anticoagulants |
| mesh[35].qualifier_ui | Q000009 |
| mesh[35].descriptor_ui | D000925 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | adverse effects |
| mesh[35].descriptor_name | Anticoagulants |
| mesh[36].qualifier_ui | Q000187 |
| mesh[36].descriptor_ui | D001777 |
| mesh[36].is_major_topic | False |
| mesh[36].qualifier_name | drug effects |
| mesh[36].descriptor_name | Blood Coagulation |
| mesh[37].qualifier_ui | |
| mesh[37].descriptor_ui | D002985 |
| mesh[37].is_major_topic | False |
| mesh[37].qualifier_name | |
| mesh[37].descriptor_name | Clinical Protocols |
| mesh[38].qualifier_ui | Q000235 |
| mesh[38].descriptor_ui | D065729 |
| mesh[38].is_major_topic | False |
| mesh[38].qualifier_name | genetics |
| mesh[38].descriptor_name | Cytochrome P-450 CYP2C9 |
| mesh[39].qualifier_ui | Q000378 |
| mesh[39].descriptor_ui | D065729 |
| mesh[39].is_major_topic | False |
| mesh[39].qualifier_name | metabolism |
| mesh[39].descriptor_name | Cytochrome P-450 CYP2C9 |
| mesh[40].qualifier_ui | |
| mesh[40].descriptor_ui | D016208 |
| mesh[40].is_major_topic | False |
| mesh[40].qualifier_name | |
| mesh[40].descriptor_name | Databases, Factual |
| mesh[41].qualifier_ui | |
| mesh[41].descriptor_ui | D005260 |
| mesh[41].is_major_topic | False |
| mesh[41].qualifier_name | |
| mesh[41].descriptor_name | Female |
| mesh[42].qualifier_ui | |
| mesh[42].descriptor_ui | D019538 |
| mesh[42].is_major_topic | False |
| mesh[42].qualifier_name | |
| mesh[42].descriptor_name | Health Care Surveys |
| mesh[43].qualifier_ui | Q000139 |
| mesh[43].descriptor_ui | D006470 |
| mesh[43].is_major_topic | False |
| mesh[43].qualifier_name | chemically induced |
| mesh[43].descriptor_name | Hemorrhage |
| mesh[44].qualifier_ui | |
| mesh[44].descriptor_ui | D006801 |
| mesh[44].is_major_topic | False |
| mesh[44].qualifier_name | |
| mesh[44].descriptor_name | Humans |
| mesh[45].qualifier_ui | |
| mesh[45].descriptor_ui | D008019 |
| mesh[45].is_major_topic | False |
| mesh[45].qualifier_name | |
| mesh[45].descriptor_name | Life Style |
| mesh[46].qualifier_ui | |
| mesh[46].descriptor_ui | D008297 |
| mesh[46].is_major_topic | False |
| mesh[46].qualifier_name | |
| mesh[46].descriptor_name | Male |
| mesh[47].qualifier_ui | |
| mesh[47].descriptor_ui | D008875 |
| mesh[47].is_major_topic | False |
| mesh[47].qualifier_name | |
| mesh[47].descriptor_name | Middle Aged |
| mesh[48].qualifier_ui | |
| mesh[48].descriptor_ui | D010597 |
| mesh[48].is_major_topic | False |
| mesh[48].qualifier_name | |
| mesh[48].descriptor_name | Pharmacogenetics |
| mesh[49].qualifier_ui | |
| mesh[49].descriptor_ui | D000071184 |
| mesh[49].is_major_topic | False |
| mesh[49].qualifier_name | |
| mesh[49].descriptor_name | Pharmacogenomic Variants |
| type | article |
| title | Rationale, design, and preliminary results of the Quebec Warfarin Cohort Study |
| biblio.issue | 5 |
| biblio.volume | 41 |
| biblio.last_page | 585 |
| biblio.first_page | 576 |
| grants[0].funder | https://openalex.org/F4320334506 |
| grants[0].award_id | |
| grants[0].funder_display_name | Canadian Institutes of Health Research |
| topics[0].id | https://openalex.org/T10065 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9998000264167786 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2705 |
| topics[0].subfield.display_name | Cardiology and Cardiovascular Medicine |
| topics[0].display_name | Atrial Fibrillation Management and Outcomes |
| topics[1].id | https://openalex.org/T10144 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9850000143051147 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2705 |
| topics[1].subfield.display_name | Cardiology and Cardiovascular Medicine |
| topics[1].display_name | Blood Pressure and Hypertension Studies |
| topics[2].id | https://openalex.org/T10217 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9836999773979187 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2705 |
| topics[2].subfield.display_name | Cardiology and Cardiovascular Medicine |
| topics[2].display_name | Cardiac electrophysiology and arrhythmias |
| funders[0].id | https://openalex.org/F4320334506 |
| funders[0].ror | https://ror.org/01gavpb45 |
| funders[0].display_name | Canadian Institutes of Health Research |
| is_xpac | False |
| apc_list.value | 2100 |
| apc_list.currency | EUR |
| apc_list.value_usd | 2475 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9658739566802979 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2776301958 |
| concepts[1].level | 3 |
| concepts[1].score | 0.8957982063293457 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q407431 |
| concepts[1].display_name | Warfarin |
| concepts[2].id | https://openalex.org/C72563966 |
| concepts[2].level | 2 |
| concepts[2].score | 0.5990527272224426 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q1303415 |
| concepts[2].display_name | Cohort |
| concepts[3].id | https://openalex.org/C126322002 |
| concepts[3].level | 1 |
| concepts[3].score | 0.4883834719657898 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[3].display_name | Internal medicine |
| concepts[4].id | https://openalex.org/C2779161974 |
| concepts[4].level | 2 |
| concepts[4].score | 0.45364829897880554 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q815819 |
| concepts[4].display_name | Atrial fibrillation |
| concepts[5].id | https://openalex.org/C201903717 |
| concepts[5].level | 2 |
| concepts[5].score | 0.4466472268104553 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q1778788 |
| concepts[5].display_name | Cohort study |
| concepts[6].id | https://openalex.org/C2780645631 |
| concepts[6].level | 2 |
| concepts[6].score | 0.440046489238739 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q671554 |
| concepts[6].display_name | Stroke (engine) |
| concepts[7].id | https://openalex.org/C2776318485 |
| concepts[7].level | 5 |
| concepts[7].score | 0.43539929389953613 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q18045930 |
| concepts[7].display_name | VKORC1 |
| concepts[8].id | https://openalex.org/C188816634 |
| concepts[8].level | 2 |
| concepts[8].score | 0.4152301847934723 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q2113324 |
| concepts[8].display_name | Prospective cohort study |
| concepts[9].id | https://openalex.org/C187212893 |
| concepts[9].level | 1 |
| concepts[9].score | 0.3225157856941223 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q123028 |
| concepts[9].display_name | Pediatrics |
| concepts[10].id | https://openalex.org/C177713679 |
| concepts[10].level | 1 |
| concepts[10].score | 0.32061123847961426 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q679690 |
| concepts[10].display_name | Intensive care medicine |
| concepts[11].id | https://openalex.org/C3946865 |
| concepts[11].level | 4 |
| concepts[11].score | 0.31612449884414673 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q5014962 |
| concepts[11].display_name | CYP2C9 |
| concepts[12].id | https://openalex.org/C78519656 |
| concepts[12].level | 1 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q101333 |
| concepts[12].display_name | Mechanical engineering |
| concepts[13].id | https://openalex.org/C526171541 |
| concepts[13].level | 3 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q407693 |
| concepts[13].display_name | Cytochrome P450 |
| concepts[14].id | https://openalex.org/C62231903 |
| concepts[14].level | 2 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q1057 |
| concepts[14].display_name | Metabolism |
| concepts[15].id | https://openalex.org/C127413603 |
| concepts[15].level | 0 |
| concepts[15].score | 0.0 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q11023 |
| concepts[15].display_name | Engineering |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9658739566802979 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/warfarin |
| keywords[1].score | 0.8957982063293457 |
| keywords[1].display_name | Warfarin |
| keywords[2].id | https://openalex.org/keywords/cohort |
| keywords[2].score | 0.5990527272224426 |
| keywords[2].display_name | Cohort |
| keywords[3].id | https://openalex.org/keywords/internal-medicine |
| keywords[3].score | 0.4883834719657898 |
| keywords[3].display_name | Internal medicine |
| keywords[4].id | https://openalex.org/keywords/atrial-fibrillation |
| keywords[4].score | 0.45364829897880554 |
| keywords[4].display_name | Atrial fibrillation |
| keywords[5].id | https://openalex.org/keywords/cohort-study |
| keywords[5].score | 0.4466472268104553 |
| keywords[5].display_name | Cohort study |
| keywords[6].id | https://openalex.org/keywords/stroke |
| keywords[6].score | 0.440046489238739 |
| keywords[6].display_name | Stroke (engine) |
| keywords[7].id | https://openalex.org/keywords/vkorc1 |
| keywords[7].score | 0.43539929389953613 |
| keywords[7].display_name | VKORC1 |
| keywords[8].id | https://openalex.org/keywords/prospective-cohort-study |
| keywords[8].score | 0.4152301847934723 |
| keywords[8].display_name | Prospective cohort study |
| keywords[9].id | https://openalex.org/keywords/pediatrics |
| keywords[9].score | 0.3225157856941223 |
| keywords[9].display_name | Pediatrics |
| keywords[10].id | https://openalex.org/keywords/intensive-care-medicine |
| keywords[10].score | 0.32061123847961426 |
| keywords[10].display_name | Intensive care medicine |
| keywords[11].id | https://openalex.org/keywords/cyp2c9 |
| keywords[11].score | 0.31612449884414673 |
| keywords[11].display_name | CYP2C9 |
| language | en |
| locations[0].id | doi:10.1002/clc.22948 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S82037729 |
| locations[0].source.issn | 0160-9289, 1932-8737 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0160-9289 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Clinical Cardiology |
| locations[0].source.host_organization | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_name | Wiley |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320595 |
| locations[0].license | |
| locations[0].pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/clc.22948 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Clinical Cardiology |
| locations[0].landing_page_url | https://doi.org/10.1002/clc.22948 |
| locations[1].id | pmid:29542828 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Clinical cardiology |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/29542828 |
| locations[2].id | pmh:oai:pubmedcentral.nih.gov:6490141 |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S2764455111 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | PubMed Central |
| locations[2].source.host_organization | https://openalex.org/I1299303238 |
| locations[2].source.host_organization_name | National Institutes of Health |
| locations[2].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | Text |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Clin Cardiol |
| locations[2].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/6490141 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5025103237 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-0066-0127 |
| authorships[0].author.display_name | Sylvie Perreault |
| authorships[0].countries | CA |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I70931966 |
| authorships[0].affiliations[0].raw_affiliation_string | Faculty of Pharmacy Université de Montréal Montreal, Quebec Canada |
| authorships[0].institutions[0].id | https://openalex.org/I70931966 |
| authorships[0].institutions[0].ror | https://ror.org/0161xgx34 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I70931966 |
| authorships[0].institutions[0].country_code | CA |
| authorships[0].institutions[0].display_name | Université de Montréal |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Sylvie Perreault |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Faculty of Pharmacy Université de Montréal Montreal, Quebec Canada |
| authorships[1].author.id | https://openalex.org/A5032622807 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Payman Shahabi |
| authorships[1].countries | CA |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I70931966 |
| authorships[1].affiliations[0].raw_affiliation_string | Faculty of Medicine Université de Montréal Montreal Quebec Canada |
| authorships[1].affiliations[1].institution_ids | https://openalex.org/I70931966 |
| authorships[1].affiliations[1].raw_affiliation_string | Université de Montréal Beaulieu‐Saucier Pharmacogenomics Centre Montreal Quebec Canada |
| authorships[1].affiliations[2].institution_ids | https://openalex.org/I2800290161 |
| authorships[1].affiliations[2].raw_affiliation_string | Montreal Heart Institute Montreal Quebec Canada |
| authorships[1].institutions[0].id | https://openalex.org/I2800290161 |
| authorships[1].institutions[0].ror | https://ror.org/03vs03g62 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I2800290161 |
| authorships[1].institutions[0].country_code | CA |
| authorships[1].institutions[0].display_name | Montreal Heart Institute |
| authorships[1].institutions[1].id | https://openalex.org/I70931966 |
| authorships[1].institutions[1].ror | https://ror.org/0161xgx34 |
| authorships[1].institutions[1].type | education |
| authorships[1].institutions[1].lineage | https://openalex.org/I70931966 |
| authorships[1].institutions[1].country_code | CA |
| authorships[1].institutions[1].display_name | Université de Montréal |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Payman Shahabi |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Faculty of Medicine Université de Montréal Montreal Quebec Canada, Montreal Heart Institute Montreal Quebec Canada, Université de Montréal Beaulieu‐Saucier Pharmacogenomics Centre Montreal Quebec Canada |
| authorships[2].author.id | https://openalex.org/A5029129015 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-0188-507X |
| authorships[2].author.display_name | Robert Côté |
| authorships[2].countries | CA |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I2800293973 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Neurology and Neurosurgery, Montreal General Hospital, Montreal, Quebec, Canada |
| authorships[2].affiliations[1].institution_ids | https://openalex.org/I5023651 |
| authorships[2].affiliations[1].raw_affiliation_string | Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada |
| authorships[2].institutions[0].id | https://openalex.org/I5023651 |
| authorships[2].institutions[0].ror | https://ror.org/01pxwe438 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I5023651 |
| authorships[2].institutions[0].country_code | CA |
| authorships[2].institutions[0].display_name | McGill University |
| authorships[2].institutions[1].id | https://openalex.org/I2800293973 |
| authorships[2].institutions[1].ror | https://ror.org/04gbhgc79 |
| authorships[2].institutions[1].type | healthcare |
| authorships[2].institutions[1].lineage | https://openalex.org/I2800293973, https://openalex.org/I2801766832 |
| authorships[2].institutions[1].country_code | CA |
| authorships[2].institutions[1].display_name | Montreal General Hospital |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Robert Côté |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada, Department of Neurology and Neurosurgery, Montreal General Hospital, Montreal, Quebec, Canada |
| authorships[3].author.id | https://openalex.org/A5048548835 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Stéphanie Dumas |
| authorships[3].countries | CA |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I70931966 |
| authorships[3].affiliations[0].raw_affiliation_string | Faculty of Pharmacy Université de Montréal Montreal, Quebec Canada |
| authorships[3].affiliations[1].institution_ids | https://openalex.org/I2800290161 |
| authorships[3].affiliations[1].raw_affiliation_string | Montreal Heart Institute Montreal Quebec Canada |
| authorships[3].affiliations[2].institution_ids | https://openalex.org/I70931966 |
| authorships[3].affiliations[2].raw_affiliation_string | Université de Montréal Beaulieu‐Saucier Pharmacogenomics Centre Montreal Quebec Canada |
| authorships[3].institutions[0].id | https://openalex.org/I2800290161 |
| authorships[3].institutions[0].ror | https://ror.org/03vs03g62 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I2800290161 |
| authorships[3].institutions[0].country_code | CA |
| authorships[3].institutions[0].display_name | Montreal Heart Institute |
| authorships[3].institutions[1].id | https://openalex.org/I70931966 |
| authorships[3].institutions[1].ror | https://ror.org/0161xgx34 |
| authorships[3].institutions[1].type | education |
| authorships[3].institutions[1].lineage | https://openalex.org/I70931966 |
| authorships[3].institutions[1].country_code | CA |
| authorships[3].institutions[1].display_name | Université de Montréal |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Stéphanie Dumas |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Faculty of Pharmacy Université de Montréal Montreal, Quebec Canada, Montreal Heart Institute Montreal Quebec Canada, Université de Montréal Beaulieu‐Saucier Pharmacogenomics Centre Montreal Quebec Canada |
| authorships[4].author.id | https://openalex.org/A5048974470 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Étienne Rouleau‐Mailloux |
| authorships[4].countries | CA |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I70931966 |
| authorships[4].affiliations[0].raw_affiliation_string | Université de Montréal Beaulieu‐Saucier Pharmacogenomics Centre Montreal Quebec Canada |
| authorships[4].affiliations[1].institution_ids | https://openalex.org/I70931966 |
| authorships[4].affiliations[1].raw_affiliation_string | Faculty of Medicine Université de Montréal Montreal Quebec Canada |
| authorships[4].affiliations[2].institution_ids | https://openalex.org/I2800290161 |
| authorships[4].affiliations[2].raw_affiliation_string | Montreal Heart Institute Montreal Quebec Canada |
| authorships[4].institutions[0].id | https://openalex.org/I2800290161 |
| authorships[4].institutions[0].ror | https://ror.org/03vs03g62 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I2800290161 |
| authorships[4].institutions[0].country_code | CA |
| authorships[4].institutions[0].display_name | Montreal Heart Institute |
| authorships[4].institutions[1].id | https://openalex.org/I70931966 |
| authorships[4].institutions[1].ror | https://ror.org/0161xgx34 |
| authorships[4].institutions[1].type | education |
| authorships[4].institutions[1].lineage | https://openalex.org/I70931966 |
| authorships[4].institutions[1].country_code | CA |
| authorships[4].institutions[1].display_name | Université de Montréal |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Étienne Rouleau‐Mailloux |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Faculty of Medicine Université de Montréal Montreal Quebec Canada, Montreal Heart Institute Montreal Quebec Canada, Université de Montréal Beaulieu‐Saucier Pharmacogenomics Centre Montreal Quebec Canada |
| authorships[5].author.id | https://openalex.org/A5083264116 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Yassamin Feroz Zada |
| authorships[5].countries | CA |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I70931966 |
| authorships[5].affiliations[0].raw_affiliation_string | Université de Montréal Beaulieu‐Saucier Pharmacogenomics Centre Montreal Quebec Canada |
| authorships[5].affiliations[1].institution_ids | https://openalex.org/I2800290161 |
| authorships[5].affiliations[1].raw_affiliation_string | Montreal Heart Institute Montreal Quebec Canada |
| authorships[5].institutions[0].id | https://openalex.org/I2800290161 |
| authorships[5].institutions[0].ror | https://ror.org/03vs03g62 |
| authorships[5].institutions[0].type | healthcare |
| authorships[5].institutions[0].lineage | https://openalex.org/I2800290161 |
| authorships[5].institutions[0].country_code | CA |
| authorships[5].institutions[0].display_name | Montreal Heart Institute |
| authorships[5].institutions[1].id | https://openalex.org/I70931966 |
| authorships[5].institutions[1].ror | https://ror.org/0161xgx34 |
| authorships[5].institutions[1].type | education |
| authorships[5].institutions[1].lineage | https://openalex.org/I70931966 |
| authorships[5].institutions[1].country_code | CA |
| authorships[5].institutions[1].display_name | Université de Montréal |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Yassamin Feroz Zada |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Montreal Heart Institute Montreal Quebec Canada, Université de Montréal Beaulieu‐Saucier Pharmacogenomics Centre Montreal Quebec Canada |
| authorships[6].author.id | https://openalex.org/A5024045589 |
| authorships[6].author.orcid | https://orcid.org/0000-0003-3133-0080 |
| authorships[6].author.display_name | Sylvie Provost |
| authorships[6].countries | CA |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I2800290161 |
| authorships[6].affiliations[0].raw_affiliation_string | Montreal Heart Institute Montreal Quebec Canada |
| authorships[6].affiliations[1].institution_ids | https://openalex.org/I70931966 |
| authorships[6].affiliations[1].raw_affiliation_string | Université de Montréal Beaulieu‐Saucier Pharmacogenomics Centre Montreal Quebec Canada |
| authorships[6].institutions[0].id | https://openalex.org/I2800290161 |
| authorships[6].institutions[0].ror | https://ror.org/03vs03g62 |
| authorships[6].institutions[0].type | healthcare |
| authorships[6].institutions[0].lineage | https://openalex.org/I2800290161 |
| authorships[6].institutions[0].country_code | CA |
| authorships[6].institutions[0].display_name | Montreal Heart Institute |
| authorships[6].institutions[1].id | https://openalex.org/I70931966 |
| authorships[6].institutions[1].ror | https://ror.org/0161xgx34 |
| authorships[6].institutions[1].type | education |
| authorships[6].institutions[1].lineage | https://openalex.org/I70931966 |
| authorships[6].institutions[1].country_code | CA |
| authorships[6].institutions[1].display_name | Université de Montréal |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Sylvie Provost |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Montreal Heart Institute Montreal Quebec Canada, Université de Montréal Beaulieu‐Saucier Pharmacogenomics Centre Montreal Quebec Canada |
| authorships[7].author.id | https://openalex.org/A5061741904 |
| authorships[7].author.orcid | https://orcid.org/0000-0003-1580-8961 |
| authorships[7].author.display_name | Ian Mongrain |
| authorships[7].countries | CA |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I2800290161 |
| authorships[7].affiliations[0].raw_affiliation_string | Montreal Heart Institute Montreal Quebec Canada |
| authorships[7].affiliations[1].institution_ids | https://openalex.org/I70931966 |
| authorships[7].affiliations[1].raw_affiliation_string | Université de Montréal Beaulieu‐Saucier Pharmacogenomics Centre Montreal Quebec Canada |
| authorships[7].institutions[0].id | https://openalex.org/I2800290161 |
| authorships[7].institutions[0].ror | https://ror.org/03vs03g62 |
| authorships[7].institutions[0].type | healthcare |
| authorships[7].institutions[0].lineage | https://openalex.org/I2800290161 |
| authorships[7].institutions[0].country_code | CA |
| authorships[7].institutions[0].display_name | Montreal Heart Institute |
| authorships[7].institutions[1].id | https://openalex.org/I70931966 |
| authorships[7].institutions[1].ror | https://ror.org/0161xgx34 |
| authorships[7].institutions[1].type | education |
| authorships[7].institutions[1].lineage | https://openalex.org/I70931966 |
| authorships[7].institutions[1].country_code | CA |
| authorships[7].institutions[1].display_name | Université de Montréal |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Ian Mongrain |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Montreal Heart Institute Montreal Quebec Canada, Université de Montréal Beaulieu‐Saucier Pharmacogenomics Centre Montreal Quebec Canada |
| authorships[8].author.id | https://openalex.org/A5006619565 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Marc Dorais |
| authorships[8].affiliations[0].raw_affiliation_string | StatSciences Inc. Notre‐Dame‐de‐l'Île‐Perrot, Quebec Canada |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Marc Dorais |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | StatSciences Inc. Notre‐Dame‐de‐l'Île‐Perrot, Quebec Canada |
| authorships[9].author.id | https://openalex.org/A5101498164 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-5082-1363 |
| authorships[9].author.display_name | Thao Huynh |
| authorships[9].countries | CA |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I2800293973 |
| authorships[9].affiliations[0].raw_affiliation_string | Department of Medicine, Montreal General Hospital, Montreal, Quebec, Canada |
| authorships[9].institutions[0].id | https://openalex.org/I2800293973 |
| authorships[9].institutions[0].ror | https://ror.org/04gbhgc79 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I2800293973, https://openalex.org/I2801766832 |
| authorships[9].institutions[0].country_code | CA |
| authorships[9].institutions[0].display_name | Montreal General Hospital |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Thao Huynh |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Department of Medicine, Montreal General Hospital, Montreal, Quebec, Canada |
| authorships[10].author.id | https://openalex.org/A5035489840 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-0860-4135 |
| authorships[10].author.display_name | Simon Kouz |
| authorships[10].countries | CA |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I3132693232 |
| authorships[10].affiliations[0].raw_affiliation_string | Département de médecine spécialisée Centre hospitalier régional de Lanaudière Joliette Quebec Canada |
| authorships[10].institutions[0].id | https://openalex.org/I3132693232 |
| authorships[10].institutions[0].ror | https://ror.org/02jqwca63 |
| authorships[10].institutions[0].type | education |
| authorships[10].institutions[0].lineage | https://openalex.org/I3132693232 |
| authorships[10].institutions[0].country_code | CA |
| authorships[10].institutions[0].display_name | Cegep regional de Lanaudiere |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Simon Kouz |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Département de médecine spécialisée Centre hospitalier régional de Lanaudière Joliette Quebec Canada |
| authorships[11].author.id | https://openalex.org/A5112863216 |
| authorships[11].author.orcid | |
| authorships[11].author.display_name | Ariel Díaz |
| authorships[11].countries | CA |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I70931966 |
| authorships[11].affiliations[0].raw_affiliation_string | Faculty of Medicine Université de Montréal Montreal Quebec Canada |
| authorships[11].affiliations[1].institution_ids | https://openalex.org/I4210120730, https://openalex.org/I70931966 |
| authorships[11].affiliations[1].raw_affiliation_string | CIUSSS‐MCQ, Université de Montréal Campus Mauricie, Trois‐Rivières, Quebec Canada |
| authorships[11].institutions[0].id | https://openalex.org/I4210120730 |
| authorships[11].institutions[0].ror | https://ror.org/02jvrpv13 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210120730 |
| authorships[11].institutions[0].country_code | CA |
| authorships[11].institutions[0].display_name | Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec |
| authorships[11].institutions[1].id | https://openalex.org/I70931966 |
| authorships[11].institutions[1].ror | https://ror.org/0161xgx34 |
| authorships[11].institutions[1].type | education |
| authorships[11].institutions[1].lineage | https://openalex.org/I70931966 |
| authorships[11].institutions[1].country_code | CA |
| authorships[11].institutions[1].display_name | Université de Montréal |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Ariel Diaz |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | CIUSSS‐MCQ, Université de Montréal Campus Mauricie, Trois‐Rivières, Quebec Canada, Faculty of Medicine Université de Montréal Montreal Quebec Canada |
| authorships[12].author.id | https://openalex.org/A5109874411 |
| authorships[12].author.orcid | |
| authorships[12].author.display_name | Mark Blostein |
| authorships[12].countries | CA |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I2801824472 |
| authorships[12].affiliations[0].raw_affiliation_string | Division of Hematology, Department of Medicine, Sir Mortimer B. Davis Jewish General Hospital, Montreal, Quebec, Canada |
| authorships[12].institutions[0].id | https://openalex.org/I2801824472 |
| authorships[12].institutions[0].ror | https://ror.org/056jjra10 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I2801824472 |
| authorships[12].institutions[0].country_code | CA |
| authorships[12].institutions[0].display_name | Jewish General Hospital |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Mark Blostein |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Division of Hematology, Department of Medicine, Sir Mortimer B. Davis Jewish General Hospital, Montreal, Quebec, Canada |
| authorships[13].author.id | https://openalex.org/A5051663627 |
| authorships[13].author.orcid | https://orcid.org/0000-0001-5404-7929 |
| authorships[13].author.display_name | Simon de Denus |
| authorships[13].countries | CA |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I70931966 |
| authorships[13].affiliations[0].raw_affiliation_string | Faculty of Pharmacy Université de Montréal Montreal, Quebec Canada |
| authorships[13].affiliations[1].institution_ids | https://openalex.org/I2800290161 |
| authorships[13].affiliations[1].raw_affiliation_string | Montreal Heart Institute Montreal Quebec Canada |
| authorships[13].affiliations[2].institution_ids | https://openalex.org/I70931966 |
| authorships[13].affiliations[2].raw_affiliation_string | Université de Montréal Beaulieu‐Saucier Pharmacogenomics Centre Montreal Quebec Canada |
| authorships[13].institutions[0].id | https://openalex.org/I2800290161 |
| authorships[13].institutions[0].ror | https://ror.org/03vs03g62 |
| authorships[13].institutions[0].type | healthcare |
| authorships[13].institutions[0].lineage | https://openalex.org/I2800290161 |
| authorships[13].institutions[0].country_code | CA |
| authorships[13].institutions[0].display_name | Montreal Heart Institute |
| authorships[13].institutions[1].id | https://openalex.org/I70931966 |
| authorships[13].institutions[1].ror | https://ror.org/0161xgx34 |
| authorships[13].institutions[1].type | education |
| authorships[13].institutions[1].lineage | https://openalex.org/I70931966 |
| authorships[13].institutions[1].country_code | CA |
| authorships[13].institutions[1].display_name | Université de Montréal |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Simon de Denus |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Faculty of Pharmacy Université de Montréal Montreal, Quebec Canada, Montreal Heart Institute Montreal Quebec Canada, Université de Montréal Beaulieu‐Saucier Pharmacogenomics Centre Montreal Quebec Canada |
| authorships[14].author.id | https://openalex.org/A5080359453 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-7978-9280 |
| authorships[14].author.display_name | Jacques Turgeon |
| authorships[14].countries | CA |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I70931966 |
| authorships[14].affiliations[0].raw_affiliation_string | Faculty of Pharmacy Université de Montréal Montreal, Quebec Canada |
| authorships[14].affiliations[1].institution_ids | https://openalex.org/I4210142730 |
| authorships[14].affiliations[1].raw_affiliation_string | Centre Hospitalier de l'Université de Montréal Montreal Quebec Canada |
| authorships[14].institutions[0].id | https://openalex.org/I4210142730 |
| authorships[14].institutions[0].ror | https://ror.org/0410a8y51 |
| authorships[14].institutions[0].type | healthcare |
| authorships[14].institutions[0].lineage | https://openalex.org/I4210142730 |
| authorships[14].institutions[0].country_code | CA |
| authorships[14].institutions[0].display_name | Centre Hospitalier de l’Université de Montréal |
| authorships[14].institutions[1].id | https://openalex.org/I70931966 |
| authorships[14].institutions[1].ror | https://ror.org/0161xgx34 |
| authorships[14].institutions[1].type | education |
| authorships[14].institutions[1].lineage | https://openalex.org/I70931966 |
| authorships[14].institutions[1].country_code | CA |
| authorships[14].institutions[1].display_name | Université de Montréal |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Jacques Turgeon |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Centre Hospitalier de l'Université de Montréal Montreal Quebec Canada, Faculty of Pharmacy Université de Montréal Montreal, Quebec Canada |
| authorships[15].author.id | https://openalex.org/A5109247748 |
| authorships[15].author.orcid | |
| authorships[15].author.display_name | Jeffrey S. Ginsberg |
| authorships[15].countries | CA |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I98251732 |
| authorships[15].affiliations[0].raw_affiliation_string | Department of Medicine, McMaster University, Hamilton, Ontario, Canada |
| authorships[15].institutions[0].id | https://openalex.org/I98251732 |
| authorships[15].institutions[0].ror | https://ror.org/02fa3aq29 |
| authorships[15].institutions[0].type | education |
| authorships[15].institutions[0].lineage | https://openalex.org/I98251732 |
| authorships[15].institutions[0].country_code | CA |
| authorships[15].institutions[0].display_name | McMaster University |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Jeffrey Ginsberg |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Department of Medicine, McMaster University, Hamilton, Ontario, Canada |
| authorships[16].author.id | https://openalex.org/A5008018875 |
| authorships[16].author.orcid | https://orcid.org/0000-0002-3236-3581 |
| authorships[16].author.display_name | Jacques LeLorier |
| authorships[16].countries | CA |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I70931966 |
| authorships[16].affiliations[0].raw_affiliation_string | Faculty of Medicine Université de Montréal Montreal Quebec Canada |
| authorships[16].affiliations[1].institution_ids | https://openalex.org/I4210142730 |
| authorships[16].affiliations[1].raw_affiliation_string | Centre Hospitalier de l'Université de Montréal Montreal Quebec Canada |
| authorships[16].institutions[0].id | https://openalex.org/I4210142730 |
| authorships[16].institutions[0].ror | https://ror.org/0410a8y51 |
| authorships[16].institutions[0].type | healthcare |
| authorships[16].institutions[0].lineage | https://openalex.org/I4210142730 |
| authorships[16].institutions[0].country_code | CA |
| authorships[16].institutions[0].display_name | Centre Hospitalier de l’Université de Montréal |
| authorships[16].institutions[1].id | https://openalex.org/I70931966 |
| authorships[16].institutions[1].ror | https://ror.org/0161xgx34 |
| authorships[16].institutions[1].type | education |
| authorships[16].institutions[1].lineage | https://openalex.org/I70931966 |
| authorships[16].institutions[1].country_code | CA |
| authorships[16].institutions[1].display_name | Université de Montréal |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Jacques Lelorier |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Centre Hospitalier de l'Université de Montréal Montreal Quebec Canada, Faculty of Medicine Université de Montréal Montreal Quebec Canada |
| authorships[17].author.id | https://openalex.org/A5113837166 |
| authorships[17].author.orcid | |
| authorships[17].author.display_name | Lyne Lalonde |
| authorships[17].countries | CA |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I70931966 |
| authorships[17].affiliations[0].raw_affiliation_string | Faculty of Pharmacy Université de Montréal Montreal, Quebec Canada |
| authorships[17].institutions[0].id | https://openalex.org/I70931966 |
| authorships[17].institutions[0].ror | https://ror.org/0161xgx34 |
| authorships[17].institutions[0].type | education |
| authorships[17].institutions[0].lineage | https://openalex.org/I70931966 |
| authorships[17].institutions[0].country_code | CA |
| authorships[17].institutions[0].display_name | Université de Montréal |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Lyne Lalonde |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Faculty of Pharmacy Université de Montréal Montreal, Quebec Canada |
| authorships[18].author.id | https://openalex.org/A5043492753 |
| authorships[18].author.orcid | https://orcid.org/0000-0002-5375-3749 |
| authorships[18].author.display_name | Lambert Busque |
| authorships[18].countries | CA |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I29045822 |
| authorships[18].affiliations[0].raw_affiliation_string | Department of Medicine Maisonneuve‐Rosemont Hospital Montreal Quebec Canada |
| authorships[18].affiliations[1].institution_ids | https://openalex.org/I29045822 |
| authorships[18].affiliations[1].raw_affiliation_string | Department of Medicine, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada |
| authorships[18].institutions[0].id | https://openalex.org/I29045822 |
| authorships[18].institutions[0].ror | https://ror.org/03rdc4968 |
| authorships[18].institutions[0].type | healthcare |
| authorships[18].institutions[0].lineage | https://openalex.org/I29045822 |
| authorships[18].institutions[0].country_code | CA |
| authorships[18].institutions[0].display_name | Hôpital Maisonneuve-Rosemont |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Lambert Busque |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | Department of Medicine Maisonneuve‐Rosemont Hospital Montreal Quebec Canada, Department of Medicine, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada |
| authorships[19].author.id | https://openalex.org/A5039491225 |
| authorships[19].author.orcid | |
| authorships[19].author.display_name | Jeannine Kassis |
| authorships[19].countries | CA |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I29045822 |
| authorships[19].affiliations[0].raw_affiliation_string | Department of Medicine Maisonneuve‐Rosemont Hospital Montreal Quebec Canada |
| authorships[19].affiliations[1].institution_ids | https://openalex.org/I29045822 |
| authorships[19].affiliations[1].raw_affiliation_string | Department of Medicine, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada |
| authorships[19].institutions[0].id | https://openalex.org/I29045822 |
| authorships[19].institutions[0].ror | https://ror.org/03rdc4968 |
| authorships[19].institutions[0].type | healthcare |
| authorships[19].institutions[0].lineage | https://openalex.org/I29045822 |
| authorships[19].institutions[0].country_code | CA |
| authorships[19].institutions[0].display_name | Hôpital Maisonneuve-Rosemont |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Jeannine Kassis |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | Department of Medicine Maisonneuve‐Rosemont Hospital Montreal Quebec Canada, Department of Medicine, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada |
| authorships[20].author.id | https://openalex.org/A5003758535 |
| authorships[20].author.orcid | https://orcid.org/0000-0001-8469-4748 |
| authorships[20].author.display_name | Mario Talajic |
| authorships[20].countries | CA |
| authorships[20].affiliations[0].institution_ids | https://openalex.org/I2800290161 |
| authorships[20].affiliations[0].raw_affiliation_string | Montreal Heart Institute, Montreal, Quebec, Canada |
| authorships[20].institutions[0].id | https://openalex.org/I2800290161 |
| authorships[20].institutions[0].ror | https://ror.org/03vs03g62 |
| authorships[20].institutions[0].type | healthcare |
| authorships[20].institutions[0].lineage | https://openalex.org/I2800290161 |
| authorships[20].institutions[0].country_code | CA |
| authorships[20].institutions[0].display_name | Montreal Heart Institute |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Mario Talajic |
| authorships[20].is_corresponding | False |
| authorships[20].raw_affiliation_strings | Montreal Heart Institute, Montreal, Quebec, Canada |
| authorships[21].author.id | https://openalex.org/A5049309607 |
| authorships[21].author.orcid | https://orcid.org/0000-0002-8200-8983 |
| authorships[21].author.display_name | Jean‐Claude Tardif |
| authorships[21].countries | CA |
| authorships[21].affiliations[0].institution_ids | https://openalex.org/I2800290161 |
| authorships[21].affiliations[0].raw_affiliation_string | Montreal Heart Institute, Montreal, Quebec, Canada |
| authorships[21].affiliations[1].institution_ids | https://openalex.org/I70931966 |
| authorships[21].affiliations[1].raw_affiliation_string | Faculty of Medicine Université de Montréal Montreal Quebec Canada |
| authorships[21].institutions[0].id | https://openalex.org/I2800290161 |
| authorships[21].institutions[0].ror | https://ror.org/03vs03g62 |
| authorships[21].institutions[0].type | healthcare |
| authorships[21].institutions[0].lineage | https://openalex.org/I2800290161 |
| authorships[21].institutions[0].country_code | CA |
| authorships[21].institutions[0].display_name | Montreal Heart Institute |
| authorships[21].institutions[1].id | https://openalex.org/I70931966 |
| authorships[21].institutions[1].ror | https://ror.org/0161xgx34 |
| authorships[21].institutions[1].type | education |
| authorships[21].institutions[1].lineage | https://openalex.org/I70931966 |
| authorships[21].institutions[1].country_code | CA |
| authorships[21].institutions[1].display_name | Université de Montréal |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Jean‐Claude Tardif |
| authorships[21].is_corresponding | False |
| authorships[21].raw_affiliation_strings | Faculty of Medicine Université de Montréal Montreal Quebec Canada, Montreal Heart Institute, Montreal, Quebec, Canada |
| authorships[22].author.id | https://openalex.org/A5021987832 |
| authorships[22].author.orcid | https://orcid.org/0000-0001-8442-4393 |
| authorships[22].author.display_name | Marie‐Pierre Dubé |
| authorships[22].countries | CA |
| authorships[22].affiliations[0].institution_ids | https://openalex.org/I70931966 |
| authorships[22].affiliations[0].raw_affiliation_string | Université de Montréal Beaulieu‐Saucier Pharmacogenomics Centre Montreal Quebec Canada |
| authorships[22].affiliations[1].institution_ids | https://openalex.org/I2800290161 |
| authorships[22].affiliations[1].raw_affiliation_string | Montreal Heart Institute Montreal Quebec Canada |
| authorships[22].affiliations[2].institution_ids | https://openalex.org/I70931966 |
| authorships[22].affiliations[2].raw_affiliation_string | Faculty of Medicine Université de Montréal Montreal Quebec Canada |
| authorships[22].institutions[0].id | https://openalex.org/I2800290161 |
| authorships[22].institutions[0].ror | https://ror.org/03vs03g62 |
| authorships[22].institutions[0].type | healthcare |
| authorships[22].institutions[0].lineage | https://openalex.org/I2800290161 |
| authorships[22].institutions[0].country_code | CA |
| authorships[22].institutions[0].display_name | Montreal Heart Institute |
| authorships[22].institutions[1].id | https://openalex.org/I70931966 |
| authorships[22].institutions[1].ror | https://ror.org/0161xgx34 |
| authorships[22].institutions[1].type | education |
| authorships[22].institutions[1].lineage | https://openalex.org/I70931966 |
| authorships[22].institutions[1].country_code | CA |
| authorships[22].institutions[1].display_name | Université de Montréal |
| authorships[22].author_position | last |
| authorships[22].raw_author_name | Marie‐Pierre Dubé |
| authorships[22].is_corresponding | True |
| authorships[22].raw_affiliation_strings | Faculty of Medicine Université de Montréal Montreal Quebec Canada, Montreal Heart Institute Montreal Quebec Canada, Université de Montréal Beaulieu‐Saucier Pharmacogenomics Centre Montreal Quebec Canada |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/clc.22948 |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Rationale, design, and preliminary results of the Quebec Warfarin Cohort Study |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10065 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9998000264167786 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2705 |
| primary_topic.subfield.display_name | Cardiology and Cardiovascular Medicine |
| primary_topic.display_name | Atrial Fibrillation Management and Outcomes |
| related_works | https://openalex.org/W2729913079, https://openalex.org/W4287377228, https://openalex.org/W2147207746, https://openalex.org/W2398504558, https://openalex.org/W2014927292, https://openalex.org/W4307362133, https://openalex.org/W2749751793, https://openalex.org/W2025668168, https://openalex.org/W3016007536, https://openalex.org/W4238096253 |
| cited_by_count | 22 |
| counts_by_year[0].year | 2024 |
| counts_by_year[0].cited_by_count | 3 |
| counts_by_year[1].year | 2023 |
| counts_by_year[1].cited_by_count | 4 |
| counts_by_year[2].year | 2022 |
| counts_by_year[2].cited_by_count | 6 |
| counts_by_year[3].year | 2021 |
| counts_by_year[3].cited_by_count | 5 |
| counts_by_year[4].year | 2020 |
| counts_by_year[4].cited_by_count | 1 |
| counts_by_year[5].year | 2019 |
| counts_by_year[5].cited_by_count | 2 |
| counts_by_year[6].year | 2018 |
| counts_by_year[6].cited_by_count | 1 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1002/clc.22948 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S82037729 |
| best_oa_location.source.issn | 0160-9289, 1932-8737 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0160-9289 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Clinical Cardiology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_name | Wiley |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/clc.22948 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Clinical Cardiology |
| best_oa_location.landing_page_url | https://doi.org/10.1002/clc.22948 |
| primary_location.id | doi:10.1002/clc.22948 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S82037729 |
| primary_location.source.issn | 0160-9289, 1932-8737 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0160-9289 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Clinical Cardiology |
| primary_location.source.host_organization | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_name | Wiley |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| primary_location.license | |
| primary_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/clc.22948 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Clinical Cardiology |
| primary_location.landing_page_url | https://doi.org/10.1002/clc.22948 |
| publication_date | 2018-03-15 |
| publication_year | 2018 |
| referenced_works | https://openalex.org/W4238924478, https://openalex.org/W2076349525, https://openalex.org/W2088917466, https://openalex.org/W2126415810, https://openalex.org/W1998354077, https://openalex.org/W1853358267, https://openalex.org/W2588108371, https://openalex.org/W2162586165, https://openalex.org/W2127985968, https://openalex.org/W2039210228, https://openalex.org/W2245741044, https://openalex.org/W2103053426, https://openalex.org/W2045271233, https://openalex.org/W2768098953, https://openalex.org/W2120064023, https://openalex.org/W1845779121, https://openalex.org/W1586488555, https://openalex.org/W2030703473, https://openalex.org/W2171017045, https://openalex.org/W2131216658, https://openalex.org/W1973420370, https://openalex.org/W2079491969, https://openalex.org/W1981830415, https://openalex.org/W1961788044, https://openalex.org/W2281540926, https://openalex.org/W2159229357, https://openalex.org/W1998377301, https://openalex.org/W2102255195, https://openalex.org/W2063976695, https://openalex.org/W2157970257, https://openalex.org/W2110258159, https://openalex.org/W2108745446, https://openalex.org/W2119721842, https://openalex.org/W2201241669, https://openalex.org/W2111947972, https://openalex.org/W2433454023, https://openalex.org/W2605500830 |
| referenced_works_count | 37 |
| abstract_inverted_index.1 | 60, 126 |
| abstract_inverted_index.3 | 57, 179 |
| abstract_inverted_index.5 | 71 |
| abstract_inverted_index.a | 149, 235, 246 |
| abstract_inverted_index.10 | 80 |
| abstract_inverted_index.71 | 153 |
| abstract_inverted_index.We | 28, 119 |
| abstract_inverted_index.as | 135 |
| abstract_inverted_index.in | 137, 141, 171, 177, 187, 245 |
| abstract_inverted_index.of | 23, 36, 92, 104, 128, 152, 197, 219 |
| abstract_inverted_index.or | 199 |
| abstract_inverted_index.to | 74, 79, 144, 190, 239 |
| abstract_inverted_index.up | 78 |
| abstract_inverted_index.1.8 | 203 |
| abstract_inverted_index.100 | 206, 215 |
| abstract_inverted_index.3.3 | 212 |
| abstract_inverted_index.56% | 175 |
| abstract_inverted_index.62% | 156 |
| abstract_inverted_index.70% | 185 |
| abstract_inverted_index.QWC | 233 |
| abstract_inverted_index.The | 40, 159, 232 |
| abstract_inverted_index.age | 151 |
| abstract_inverted_index.and | 1, 9, 14, 20, 32, 62, 68, 77, 90, 94, 116, 123, 155, 184, 230, 242 |
| abstract_inverted_index.are | 5 |
| abstract_inverted_index.for | 34, 59, 70, 163, 208 |
| abstract_inverted_index.had | 148 |
| abstract_inverted_index.new | 47 |
| abstract_inverted_index.per | 205, 214 |
| abstract_inverted_index.the | 21, 102, 142, 178, 188, 195 |
| abstract_inverted_index.was | 88, 97, 133, 165, 174, 202 |
| abstract_inverted_index.1059 | 46 |
| abstract_inverted_index.3‐ | 143, 189 |
| abstract_inverted_index.Mean | 169 |
| abstract_inverted_index.Poor | 130 |
| abstract_inverted_index.age. | 231 |
| abstract_inverted_index.good | 236 |
| abstract_inverted_index.mean | 150 |
| abstract_inverted_index.men. | 158 |
| abstract_inverted_index.most | 160 |
| abstract_inverted_index.poor | 37, 220 |
| abstract_inverted_index.rate | 196 |
| abstract_inverted_index.test | 33 |
| abstract_inverted_index.this | 24 |
| abstract_inverted_index.time | 105, 136, 170 |
| abstract_inverted_index.were | 157, 223 |
| abstract_inverted_index.with | 3, 7, 50 |
| abstract_inverted_index.year | 127 |
| abstract_inverted_index.(QWC) | 44 |
| abstract_inverted_index.(RAMQ | 67 |
| abstract_inverted_index.after | 125 |
| abstract_inverted_index.dose, | 114 |
| abstract_inverted_index.entry | 76 |
| abstract_inverted_index.every | 56 |
| abstract_inverted_index.genes | 96 |
| abstract_inverted_index.heart | 227 |
| abstract_inverted_index.major | 209 |
| abstract_inverted_index.prior | 73 |
| abstract_inverted_index.range | 139, 173 |
| abstract_inverted_index.spent | 107 |
| abstract_inverted_index.using | 53, 63 |
| abstract_inverted_index.year, | 61 |
| abstract_inverted_index.years | 72, 81 |
| abstract_inverted_index.(87%). | 168 |
| abstract_inverted_index.CYP2C9 | 93 |
| abstract_inverted_index.Cohort | 43 |
| abstract_inverted_index.During | 193 |
| abstract_inverted_index.Quebec | 41 |
| abstract_inverted_index.VKORC1 | 95 |
| abstract_inverted_index.active | 83 |
| abstract_inverted_index.affect | 17 |
| abstract_inverted_index.atrial | 166 |
| abstract_inverted_index.causes | 22 |
| abstract_inverted_index.cohort | 75, 238 |
| abstract_inverted_index.common | 161 |
| abstract_inverted_index.events | 204, 213 |
| abstract_inverted_index.kidney | 225 |
| abstract_inverted_index.months | 58, 180 |
| abstract_inverted_index.range, | 110 |
| abstract_inverted_index.remain | 26 |
| abstract_inverted_index.report | 120 |
| abstract_inverted_index.stroke | 198 |
| abstract_inverted_index.users, | 49 |
| abstract_inverted_index.within | 108 |
| abstract_inverted_index.years, | 154 |
| abstract_inverted_index.<60% | 140 |
| abstract_inverted_index.(±21%) | 186 |
| abstract_inverted_index.(±25%) | 176 |
| abstract_inverted_index.Genetic | 13, 86 |
| abstract_inverted_index.Over‐ | 0 |
| abstract_inverted_index.chronic | 224 |
| abstract_inverted_index.control | 132, 222 |
| abstract_inverted_index.defined | 134 |
| abstract_inverted_index.events, | 11, 211 |
| abstract_inverted_index.events. | 118 |
| abstract_inverted_index.factors | 16, 244 |
| abstract_inverted_index.genetic | 243 |
| abstract_inverted_index.patient | 84 |
| abstract_inverted_index.present | 29 |
| abstract_inverted_index.Measured | 99 |
| abstract_inverted_index.Warfarin | 42 |
| abstract_inverted_index.baseline | 121 |
| abstract_inverted_index.bleeding | 210 |
| abstract_inverted_index.clinical | 15, 241 |
| abstract_inverted_index.control, | 112 |
| abstract_inverted_index.control. | 39 |
| abstract_inverted_index.disease, | 226 |
| abstract_inverted_index.embolism | 201 |
| abstract_inverted_index.failure, | 228 |
| abstract_inverted_index.included | 101 |
| abstract_inverted_index.material | 87 |
| abstract_inverted_index.outcomes | 100, 124 |
| abstract_inverted_index.patients | 106 |
| abstract_inverted_index.research | 237 |
| abstract_inverted_index.systemic | 200 |
| abstract_inverted_index.unclear. | 27 |
| abstract_inverted_index.warfarin | 4, 18, 48, 113, 164, 182 |
| abstract_inverted_index.bleeding, | 115 |
| abstract_inverted_index.comprises | 45 |
| abstract_inverted_index.databases | 66 |
| abstract_inverted_index.following | 82, 181 |
| abstract_inverted_index.interval. | 146, 192 |
| abstract_inverted_index.response, | 19 |
| abstract_inverted_index.telephone | 54 |
| abstract_inverted_index.12‐month | 145, 191 |
| abstract_inverted_index.associated | 6 |
| abstract_inverted_index.collected, | 89 |
| abstract_inverted_index.conducted. | 98 |
| abstract_inverted_index.genotyping | 91 |
| abstract_inverted_index.healthcare | 64 |
| abstract_inverted_index.indication | 162 |
| abstract_inverted_index.percentage | 103 |
| abstract_inverted_index.predictors | 35, 218 |
| abstract_inverted_index.represents | 234 |
| abstract_inverted_index.statistics | 31 |
| abstract_inverted_index.Independent | 217 |
| abstract_inverted_index.Med‐Echo) | 69 |
| abstract_inverted_index.descriptive | 30 |
| abstract_inverted_index.follow‐up | 52 |
| abstract_inverted_index.hemorrhagic | 8 |
| abstract_inverted_index.initiation, | 183 |
| abstract_inverted_index.investigate | 240 |
| abstract_inverted_index.population. | 248 |
| abstract_inverted_index.prospective | 51 |
| abstract_inverted_index.therapeutic | 109, 138, 172 |
| abstract_inverted_index.variability | 25 |
| abstract_inverted_index.Participants | 147 |
| abstract_inverted_index.fibrillation | 167 |
| abstract_inverted_index.follow‐up, | 194 |
| abstract_inverted_index.follow‐up. | 129 |
| abstract_inverted_index.dyslipidemia, | 229 |
| abstract_inverted_index.respectively. | 12 |
| abstract_inverted_index.administrative | 65 |
| abstract_inverted_index.participation. | 85 |
| abstract_inverted_index.questionnaires | 55 |
| abstract_inverted_index.thromboembolic | 10, 117 |
| abstract_inverted_index.anticoagulation | 38, 111, 131, 221 |
| abstract_inverted_index.characteristics | 122 |
| abstract_inverted_index.person‐years. | 216 |
| abstract_inverted_index.person‐years; | 207 |
| abstract_inverted_index.undercoagulation | 2 |
| abstract_inverted_index.warfarin‐anticoagulated | 247 |
| cited_by_percentile_year.max | 98 |
| cited_by_percentile_year.min | 89 |
| corresponding_author_ids | https://openalex.org/A5021987832 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 23 |
| corresponding_institution_ids | https://openalex.org/I2800290161, https://openalex.org/I70931966 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/1 |
| sustainable_development_goals[0].score | 0.6200000047683716 |
| sustainable_development_goals[0].display_name | No poverty |
| citation_normalized_percentile.value | 0.83851907 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |